«The ability to provide a treatment that can increase stress resiliency at the cellular level, and hopefully also the behavioral level, would be a much welcomed addition to
our antidepressant armamentarium,» says Gerard Sanacora, a professor of psychiatry at Yale University School of Medicine and director of the Yale Depression Research Program.